Dual-color detection of DNA sequence variants by ligase-mediated analysis.
Genetic screening for sequence variants associated with disease is assuming increasing importance in clinical medicine as well as in research. We describe an efficient method for such analyses, comprising a combination of practical features: (1) Amplified DNA samples are analyzed for their ability to serve as templates in standardized allele-specific ligation reactions between oligonucleotide probes; (2) Two allele-specific probes, differentially labeled with either of two lanthanide labels, compete for ligation to a third oligonucleotide (the signal from the two labeled probes can thus be directly compared in a sensitive time-resolved fluorescence detection reaction); and (3) Large sets of analyses are processed in parallel using a 96-pin capture manifold, serving to reduce pipetting steps and the risk of contamination. We present here the basis of the technique and its application to the screening for two common mutations causing cystic fibrosis and alpha 1-antiytrypsin deficiency.
Samiotaki
M
M
Department of Medical Genetics, Beijer Laboratory, Uppsala University, Sweden.
Kwiatkowski
M
M
Parik
J
J
Landegren
U
U
D001483:Base Sequence; D003124:Colorimetry / Q000379:methods*; D003550:Cystic Fibrosis / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D004247:DNA; D011088:DNA Ligases / Q000378:metabolism*; D014644:Genetic Variation; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics*; D008969:Molecular Sequence Data; D009154:Mutation; D000515:alpha 1-Antitrypsin / Q000235:genetics*
C505032:CFTR protein, human; D008565:Membrane Proteins; D000515:alpha 1-Antitrypsin; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D004247:DNA; D011088:DNA Ligases